Vimarsana
Biggest News Aggregation in the World

Page 3 - Agonist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agonist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agonist Today - Breaking & Trending Today

Cannabis and derivatives show promise in reducing weight and waist circumference, with nuanced effects on body fat - Vimarsana News

Cannabis and derivatives show promise in reducing weight and waist circumference, with nuanced effects on body fat

The study in the International Journal of Obesity reports that cannabis and its derivatives may influence weight and waist circumference, with different effects on body fat, suggesting potential as a therapeutic aid in obesity management.

Does the timing of prenatal exposure to corticosteroids and β2-agonists impact a child's neurodevelopment by age 3? - Vimarsana News

Does the timing of prenatal exposure to corticosteroids and β2-agonists impact a child's neurodevelopment by age 3?

Researchers investigated the association between the timing of in-utero exposure to β2-agonists and corticosteroids and offspring neurodevelopmental milestones during the initial three years of life.

Researchers discover new way to trigger programmed cell death in cancer cells - Vimarsana News

Researchers discover new way to trigger programmed cell death in cancer cells

A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.

Ketamine's long-lasting antidepressant effects unveiled in new study - Vimarsana News

Ketamine's long-lasting antidepressant effects unveiled in new study

Persistent blocking of NMDAR and burst-type firing by lateral habenula (LHb) neurons may offer a basis for the long-lasting antidepressant effects of ketamine.

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing - Vimarsana News

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

The study reveals a significant increase in the usage of GLP-1 receptor agonists, particularly Ozempic and Trulicity, for weight management and Type 2 diabetes in the U.S. from 2014 to 2022. Amidst rapid growth and shortages, the paper calls for evidence-based decision-making to ensure stable medication supply and effective treatment.